Business

EU Regulator Clears Pfizer's Covid-19 Vaccine For Children Aged 5 To 11

13 days ago   |   By Forbes

It is the first time the regulator has authorized a Covid-19 vaccine for use in young children.
Read more ...

 

The EU's drug regulator recommends Pfizer's vaccine as the first COVID-19 shot for 5 to 11 year olds in Europe

13 days ago   |   By Business Insider

Pfizer-BioNTech's vaccine will be given in two doses of 10 micrograms three weeks apart as an injection in the upper arm, the European Medicines Agency recommended. Reuters
The EU is set to soon allow young children to get their first shot of a COVID-19 vaccine.
Its drug regulator on Thursday recommended approval for Pfizer's vaccine for kids aged five to 11.
Europe is battling a surge in infections, and accounts for around half of global cases.
The European Union's drug regulator recommended the use of Pfizer-BioNTech's COVID-19 vaccine for children between the ages of five and 11 on...
Read more ...

 

EU regulator authorizes Pfizer's COVID vaccine for kids 5-11

EU regulator authorizes Pfizer's COVID vaccine for kids 5-11

13 days ago   |   By Stl Today

THE HAGUE, Netherlands - The European Union's drug regulator on Thursday authorized Pfizer's coronavirus vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils...
Read more ...

 

European Union authorizes Pfizer's COVID-19 vaccine for kids 5 to 11

13 days ago   |   By Stl Today

THE HAGUE, Netherlands - European Union authorizes Pfizer's COVID-19 vaccine for kids 5 to 11.
Read more ...

 

EU regulator authorizes Pfizer's COVID vaccine for kids 5-11

13 days ago   |   By Chron

THE HAGUE, Netherlands - The European Union drugs regulator authorized Pfizer's coronavirus vaccine for use on children aged from 5 to 11 years on Thursday, clearing the way for shots to be administered to millions of elementary school children on the continent amid a new wave of infections sweeping across Europe.
It is the first time the European Medicines Agency has cleared a COVID-19 vaccine for use in young children.
The agency said it “recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.”
Read more ...

 


Search by Tags

   Business      Business      Innovation      Innovation      Healthcare      Healthcare      Breaking      Breaking-news      Coronavirus      Coronavirus      Europe      News      Pfizer      EMA      EU      European Union      Biontech      Pfizer vaccine      Coronavirus vaccine      COVID-19      Covid vaccine      COVID-19 vaccine      Indices  


Macquarie Initiates Coverage on Pinduoduo

Macquarie Initiates Coverage on Pinduoduo

Investment analysts at Macquarie began coverage on shares of Pinduoduo in a research note issued to investors on Tuesday, The Fly reports. The firm set an “outperform” rating... Read more ...

SL Private Equity Hits New 52-Week High at $536.03

SL Private Equity Hits New 52-Week High at $536.03

Shares of SL Private Equity reached a new 52-week high during mid-day trading on Tuesday. The company traded as high as GBX 536.03 and last traded at GBX 531.60 , with a volume... Read more ...

Comparing BIT Mining and The Competition

Comparing BIT Mining and The Competition

BIT Mining is one of 29 publicly-traded companies in the “Miscellaneous amusement & recreation services” industry, but how does it contrast to its competitors? We will compare... Read more ...

The FC Barcelona Players Who No Longer Deserve To Be Starters

FC Barcelona are summoned to Europa League football following a woeful 3-0 loss to Bayern Munich in the Champions League. Among other things, the defeat highlighted a series of... Read more ...

Analysts Expect AMERISAFE, Inc. Will Announce Earnings of $0.86 Per Share

Analysts Expect AMERISAFE, Inc. Will Announce Earnings of $0.86 Per Share

Analysts expect AMERISAFE, Inc. to post earnings of $0.86 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates... Read more ...

Capital One Financial PT Raised to $221.00

Capital One Financial PT Raised to $221.00

Capital One Financial had its price objective lifted by Morgan Stanley from $214.00 to $221.00 in a research report released on Monday, PriceTargets.com reports. The firm... Read more ...

Desjardins Raises Bank of Montreal Price Target to C$150.00

Desjardins Raises Bank of Montreal Price Target to C$150.00

Bank of Montreal had its target price hoisted by Desjardins from C$146.00 to C$150.00 in a research report sent to investors on Tuesday, The Fly reports. They currently have a... Read more ...

Mambu nabs $266M at a $5.5B valuation to double down on embedded financial...

Embedded finance - where companies tap into APIs to integrate banking and other financial tools without having to build everything themselves from the ground up - has been one... Read more ...

Schnitzer Steel Industries Shares Gap Up to $47.14

Schnitzer Steel Industries Shares Gap Up to $47.14

Schnitzer Steel Industries, Inc. 's stock price gapped up before the market opened on Tuesday. The stock had previously closed at $47.14, but opened at $50.98. Schnitzer Steel... Read more ...

Crescent Point Energy Hits New 1-Year High at $6.59

Crescent Point Energy Hits New 1-Year High at $6.59

Crescent Point Energy Corp. 's stock price reached a new 52-week high on Tuesday. The stock traded as high as C$6.59 and last traded at C$6.59, with a volume of 2405693 shares... Read more ...